ES8504486A1 - Procedimiento de trituracion de compuestos esteroides - Google Patents
Procedimiento de trituracion de compuestos esteroidesInfo
- Publication number
- ES8504486A1 ES8504486A1 ES526874A ES526874A ES8504486A1 ES 8504486 A1 ES8504486 A1 ES 8504486A1 ES 526874 A ES526874 A ES 526874A ES 526874 A ES526874 A ES 526874A ES 8504486 A1 ES8504486 A1 ES 8504486A1
- Authority
- ES
- Spain
- Prior art keywords
- steroid compounds
- compounds
- particles
- particle size
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA TRITURACION DE COMPUESTOS ESTEROIDES, EN PARTICULAR DE 2BAB-CIANO-4BAB,5BAB-EPOXI-3-OXO-ESTEROIDES QUE TIENEN ENTRE 19 Y 23 ATOMOS DE CARBONO EXCLUYENDO LOS RADICALES ESTER Y QUE TIENEN UNA ESTRUCTURA DE ANILLO BASICO DE FORMULA GENERAL (I).CONSISTE EN SOMETER EL ESTEROIDE EN BRUTO A UN TRATAMIENTO CONTINUO DURANTE UN TIEMPO SUFICIENTE O REPETIDO, PARA REDUCIR SU TAMAN/O DE PARTICULA Y PROPORCIONAR UN COMPUESTO EN FORMA DE PARTICULAS CON TAMAN/O INFERIOR A 20 MICRAS POR TERMINO MEDIO.DE APLICACION EN LA PREPARACION DE DETERMINADAS COMPOSICIONES FARMACEUTICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8231278 | 1982-11-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8504486A1 true ES8504486A1 (es) | 1985-05-01 |
ES526874A0 ES526874A0 (es) | 1985-05-01 |
Family
ID=10533991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES526874A Granted ES526874A0 (es) | 1982-11-02 | 1983-10-28 | Procedimiento de trituracion de compuestos esteroides |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0108606B1 (es) |
JP (1) | JPS5995300A (es) |
AT (1) | ATE38236T1 (es) |
DE (1) | DE3378318D1 (es) |
DK (1) | DK499683A (es) |
ES (1) | ES526874A0 (es) |
FI (1) | FI834025A (es) |
GB (1) | GB2130588B (es) |
GR (1) | GR79688B (es) |
IE (1) | IE56205B1 (es) |
NO (1) | NO833976L (es) |
PT (1) | PT77593B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8328929D0 (en) | 1983-10-29 | 1983-11-30 | Sterwin Ag | Steroid compounds |
US6458811B1 (en) | 1996-03-26 | 2002-10-01 | Eli Lilly And Company | Benzothiophenes formulations containing same and methods |
GB2345851B (en) * | 2000-01-18 | 2004-05-26 | Gavin Paul Vinson | A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour |
GB2375958B (en) * | 2001-04-09 | 2005-03-02 | George Margetts | The use of steroids to lower the levels of cortisol |
GB2400554B (en) * | 2003-04-16 | 2007-04-18 | George Margetts | Treatment of angiotensin II-induced cardiovascular disease |
EP2468318A1 (en) | 2005-07-12 | 2012-06-27 | DMI Biosciences, Inc. | Methods and products for treatment of diseases |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3296255A (en) * | 1963-11-29 | 1967-01-03 | Sterling Drug Inc | 2-cyano steroids |
GB1123770A (en) * | 1966-11-15 | 1968-08-14 | Sterling Drug Inc | 2-cyano-3-oxo-steroids |
FR2408345A1 (fr) * | 1976-11-30 | 1979-06-08 | Besins Jean Louis | Nouvelle composition a action anti-conceptionnelle |
US4062954A (en) * | 1976-12-27 | 1977-12-13 | Sterling Drug Inc. | Process for using a steroid compound |
US4160027A (en) * | 1977-12-20 | 1979-07-03 | Sterling Drug Inc. | Steroid cyanoketones and intermediates |
GB8328929D0 (en) | 1983-10-29 | 1983-11-30 | Sterwin Ag | Steroid compounds |
-
1983
- 1983-10-28 ES ES526874A patent/ES526874A0/es active Granted
- 1983-10-28 JP JP58202482A patent/JPS5995300A/ja active Granted
- 1983-11-01 DK DK499683A patent/DK499683A/da not_active Application Discontinuation
- 1983-11-01 GB GB08329173A patent/GB2130588B/en not_active Expired
- 1983-11-01 NO NO833976A patent/NO833976L/no unknown
- 1983-11-02 IE IE2563/83A patent/IE56205B1/en not_active IP Right Cessation
- 1983-11-02 EP EP83306665A patent/EP0108606B1/en not_active Expired
- 1983-11-02 PT PT77593A patent/PT77593B/pt not_active IP Right Cessation
- 1983-11-02 GR GR72848A patent/GR79688B/el unknown
- 1983-11-02 FI FI834025A patent/FI834025A/fi not_active Application Discontinuation
- 1983-11-02 AT AT83306665T patent/ATE38236T1/de not_active IP Right Cessation
- 1983-11-02 DE DE8383306665T patent/DE3378318D1/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IE832563L (en) | 1984-05-02 |
GB2130588B (en) | 1986-08-13 |
EP0108606A1 (en) | 1984-05-16 |
EP0108606B1 (en) | 1988-10-26 |
PT77593A (en) | 1983-12-01 |
JPS5995300A (ja) | 1984-06-01 |
JPH0443078B2 (es) | 1992-07-15 |
NO833976L (no) | 1984-05-03 |
DK499683D0 (da) | 1983-11-01 |
FI834025A (fi) | 1984-05-03 |
PT77593B (en) | 1986-03-18 |
FI834025A0 (fi) | 1983-11-02 |
DE3378318D1 (en) | 1988-12-01 |
IE56205B1 (en) | 1991-05-22 |
DK499683A (da) | 1984-05-03 |
GR79688B (es) | 1984-10-31 |
ATE38236T1 (de) | 1988-11-15 |
GB8329173D0 (en) | 1983-12-07 |
ES526874A0 (es) | 1985-05-01 |
GB2130588A (en) | 1984-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES470335A1 (es) | Un metodo para preparar una composicion que contiene carbonoen forma purificada y pulverizada,asi como agua y un agente dispersante | |
EP0097031A3 (en) | Nonapeptide and decapeptide analogs of lhrh useful as lhrh antagonists, their preparation and compositions containing them | |
ZA957609B (en) | Granular compositions | |
GR78080B (es) | ||
Katyare et al. | Heterogeneity of rat liver mitochondrial fractions and the effect of tri-iodothyronine on their protein turnover | |
ES8504486A1 (es) | Procedimiento de trituracion de compuestos esteroides | |
ZA85104B (en) | The use of salicyclic acid esters as perfumes,perfume compositions containing them and new salicyclic esters | |
JPS57140716A (en) | Antiallergic agent | |
IL70124A (en) | 5,14-dihydrobenz(5,6)isoindolo(2,1-b)isoquinoline-8,13-dione,its preparation and pharmaceutical compositions containing it | |
IE810232L (en) | Phenyl hydroxyalkyl ethers and thioethers | |
DE3474024D1 (en) | Contraceptive compositions based on esters of levo-norgestrel | |
JPS5758626A (en) | Carcinostatic agent | |
DE3162067D1 (en) | Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions | |
JPS5668611A (en) | Novel antiallergic agent | |
JPS57140715A (en) | Antitumor agent | |
CA2104086A1 (en) | Metallothermal Reaction Mixture | |
JPS54125663A (en) | Carcinostatic agent and novel compound having carcinostatic activity | |
JPS5771732A (en) | Electric discharge machining liquid | |
JPS53131565A (en) | Powder particle mixer | |
FR2361104B2 (es) | ||
JPS5762203A (en) | Production of halogenated sulfone preparation | |
JPS56110623A (en) | Carcinostatic agent | |
JPS57108017A (en) | Antithrombotic agent | |
JPS57123121A (en) | Thrombolytic agent | |
JPS57108016A (en) | Antithrombotic agent |